<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
< Back to all Breaking News
CAHC, TMDX, HYLN...
4/7/2021 08:04am
Fly Intel: Pre-market Movers

Check out this morning's top movers from around Wall Street, compiled by The Fly. 


HIGHER -

  • CA Healthcare Acquisition (CAHC) up 7% after announcing a definitive merger agreement with LumiraDx, a point of care diagnostics testing company
  • TransMedics (TMDX) up 11% after announcing that after the review of TransMedics' clinical evidence from the OCS Heart EXPAND trial, the associated Continued Access Protocol results, as well as the OCS Heart PROCEED II trial, the Circulatory Systems Device Advisory Panel convened by the FDA has issued a favorable vote in support of approval of the OCS Heart System to the FDA's Office of Health Technology
  • Hyliion Holdings (HYLN) up 9% after forming the Hypertruck Innovation Council, a group of fleet, logistics, and transportation industry leaders that will support the development of Hyliion's Hypertruck powertrain solution

UP AFTER EARNINGS -

  • Himax (HIMX) up 6%
  • Simply Good Foods (SMPL) up 1%


DOWN AFTER EARNINGS -

  • MSC Industrial (MSM) down 1%
  • RPM (RPM) down 1%


LOWER -

  • FibroGen (FGEN) down 29% after announcing that that the FDA has informed the company that it has tentatively scheduled a Cardiovascular and Renal Drug Advisory Committee on July 15 to review the new drug application for roxadustat for the treatment of anemia of chronic kidney disease in both dialysis-dependent and non-dialysis-dependent patients
  • Homology Medicines (FIXX) down 15% after announcing $50M stock offering
  • Upstart (UPST) down 4% after filing to sell 2M shares of common stock

dynamic_feed Breaking News